In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response ; volume:21 ; number:1 ; day:18 ; month:1 ; year:2019 ; pages:1-8 ; date:12.2019
Arthritis Research & Therapy ; 21, Heft 1 (18.1.2019), 1-8, 12.2019
- Creator
-
Moel, Emma C. de
Derksen, Veerle F. A. M.
Trouw, Leendert A.
Bang, Holger
Collée, Gerard
Lard, Leroy R.
Ramiro, Sofia
Huizinga, Tom W. J.
Allaart, Cornelia F.
Toes, René E. M.
Woude, Diane van der
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-019-1815-0
- URN
-
urn:nbn:de:101:1-2019022022580727514101
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moel, Emma C. de
- Derksen, Veerle F. A. M.
- Trouw, Leendert A.
- Bang, Holger
- Collée, Gerard
- Lard, Leroy R.
- Ramiro, Sofia
- Huizinga, Tom W. J.
- Allaart, Cornelia F.
- Toes, René E. M.
- Woude, Diane van der
- SpringerLink (Online service)
Other Objects (12)
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity
Immunosuppression
Chemical immunosuppression
Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity
Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis
Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab
The flow limit of reflect-reflect-relax
Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis
Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity
Immunosuppression
Chemical immunosuppression
Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity
Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis
Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab
The flow limit of reflect-reflect-relax
Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis
Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity
Immunosuppression
Chemical immunosuppression
Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity
Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis
Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab
The flow limit of reflect-reflect-relax
Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis